← Leaderboards
Richard Gordon Bach
Pulse Therapeutics, Inc.
$583,627
Attributed
$1,167,254
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $465.1K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,167,254 · 3
By mechanism
R43$1,167,254 · 3
Top collaborators
- Francis Milton Creighton3 shared
- Dana R Abendschein1 shared
Most similar at Pulse Therapeutics, Inc.
Same institution · by research overlap
- Francis Milton Creighton$7,398,011
- Michael Anthony Tones$804,988
- William James Harrison$513,475
- Martin Omid Akhavan$530,790
Others in their field
Other Emerging Leaders on “Percutaneous Coronary Intervention”
- Ioannis S Chatzizisis · University Of Nebraska Medical Center$3,941,144
- Diann E Gaalema · University Of Vermont & St Agric College$3,871,707
- Nestor Uribe-Patarroyo · Massachusetts General Hospital$3,329,100
- Sayeh Sander Nikpay · University Of Minnesota$2,454,092
- Lewis Schwartz · Efemoral Medical, Inc.$2,126,052
- Pinar Zorlutuna · University Of Notre Dame$1,942,353
Research focus
Percutaneous Coronary InterventionCostUnderserved PopulationCessation Of LifeMeetingsMagnetismMortalityPrototypeUnited StatesBlood FlowMyocardial InfarctionCoronary Heart DiseaseAtherectomyDangerousnessCoronary Artery CalcificationCoronary LesionGenerationsEconomic BurdenAdultFeasibility StudiesBlood VesselsAnimalsCalcificationCardiovascular Diseases
Grant awards (4)
Magnetic Rotational Platform for Coronary Lesions$413,595
R43 · FY2025 · HL
Magnetic Rotational Exploratory Platform for Coronary Lesions$456,397
R43 · FY2022 · HL
Magnetic Rotational Exploratory Platform for Coronary Lesions$8,700
R43 · FY2022 · HL
Magnetic Targeting and Dose Reduction of Tenecteplase in the Treatment of STEMI for Underserved Populations$288,562
R43 · FY2018 · MD